Table 2—

Distribution of baseline sleep duration in cohort members in the at-risk sample, those in the analytic sample, and those not in the analytic sample, MMAS, Boston, MA, 1987–2004

Sleep durationAt-risk sample*In analytic sampleNot in analytic sample
n 1,564 1,139 425 
≤5 h 147 (9.4) 95 (8.3) 52 (12.2) 
6 h 309 (19.8) 223 (19.6) 86 (20.2) 
7 h 554 (35.4) 423 (37.1) 131 (30.8) 
8 h 453 (29.0) 328 (28.8) 125 (29.4) 
>8 h 101 (6.5) 70 (6.2) 31 (7.3) 
Sleep durationAt-risk sample*In analytic sampleNot in analytic sample
n 1,564 1,139 425 
≤5 h 147 (9.4) 95 (8.3) 52 (12.2) 
6 h 309 (19.8) 223 (19.6) 86 (20.2) 
7 h 554 (35.4) 423 (37.1) 131 (30.8) 
8 h 453 (29.0) 328 (28.8) 125 (29.4) 
>8 h 101 (6.5) 70 (6.2) 31 (7.3) 

Data are n (%).

*

Men in the at-risk sample were those without diabetes at baseline (n = 1,567). Additional exclusions were for missing sleep duration (n = 2) and age (n = 1) data.

Men in the analytic sample were those in the at-risk sample who could be classified according to diabetes status during follow-up.

Close Modal

or Create an Account

Close Modal
Close Modal